← Back to Search

Caregiver-Support for Caregiver Burnout

N/A
Waitlist Available
Led By Martha Abshire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks and 32 weeks
Awards & highlights

Study Summary

This trial is testing whether providing support services to caregivers can improve quality of life for both the caregiver and the care recipient.

Eligible Conditions
  • Caregiver Burnout

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks and 32 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks and 32 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Life as Assessed by the Short Form Health Survey
Secondary outcome measures
Caregiver Burden as Assessed by the Oberst Caregiving Burden Scale
Caregiver Burden as Assessed by the Zarit Caregiver Burden Interview (ZBI)
Fatigue as Assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)
Other outcome measures
Change in Interleukin 10 (pg/ml)
Change in Interleukin 6 (ng/mL)
Change in Resilience to Stress as Assessed by Heart Rate Variability

Trial Design

3Treatment groups
Experimental Treatment
Group I: Waitlist ControlExperimental Treatment1 Intervention
The waitlist control group (n=20) will be provided written materials with community resources for caregivers during the first 16 weeks, then the intervention will begin.
Group II: Open Label GroupExperimental Treatment1 Intervention
In this arm, 5 participants will be enrolled in the intervention without blinding or randomization. The intervention and study delivery will be improved based on findings from this arm.
Group III: Immediate InterventionExperimental Treatment1 Intervention
The immediate intervention group (n=20) will receive the intervention during weeks 0-16. There will be assessment at week 32 to examine maintenance on primary and secondary outcomes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Caregiver-Support
2020
N/A
~40

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,256 Previous Clinical Trials
14,820,033 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
579 Previous Clinical Trials
10,376,344 Total Patients Enrolled
Martha Abshire, PhDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Caregiver Support in the Context of Multiple Chronic Conditions
2020. "Caregiver Support in the Context of Multiple Chronic Conditions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04090749.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top